Fukuchi Y, Kumagai T, Ebina K, Yokota K
Pharmacy, Japanese Red Cross Sendai Hospital, Japan.
Biol Pharm Bull. 1996 Apr;19(4):547-50. doi: 10.1248/bpb.19.547.
We investigated the effect of human blood plasma lipoproteins on the hemolytic activity of Asp-hemolysin. Apolipoprotein B (apoB)-containing lipoproteins, such as low density lipoprotein (LDL) and very low density lipoprotein (VLDL), inhibit the activity of this hemolytic toxin. When Asp-hemolysin (15 mu g) was incubated with 100 mu g LDL (as protein), the hemolytic activity was inhibited by 90%. When 20 mu g apoB was added, the hemolytic activity was almost completely inhibited. Furthermore, similar inhibition was obtained in the filtrates which were separated from the incubation mixture of Asp-hemolysin with LDL or apoB following ultrafiltration through a membrane with a molecular cutoff = 100000. The current findings suggest that the inhibition by LDL is due to apoB binding to Asp-hemolysin.
我们研究了人血浆脂蛋白对天冬氨酸溶血素溶血活性的影响。含载脂蛋白B(apoB)的脂蛋白,如低密度脂蛋白(LDL)和极低密度脂蛋白(VLDL),可抑制这种溶血毒素的活性。当天冬氨酸溶血素(15μg)与100μg LDL(以蛋白质计)孵育时,溶血活性被抑制90%。当加入20μg apoB时,溶血活性几乎完全被抑制。此外,通过分子截留量为100000的膜对天冬氨酸溶血素与LDL或apoB的孵育混合物进行超滤后,在滤液中也获得了类似的抑制作用。目前的研究结果表明,LDL的抑制作用是由于apoB与天冬氨酸溶血素结合所致。